vs
Axsome Therapeutics, Inc.（AXSM）与JBG SMITH Properties（JBGS）财务数据对比。点击上方公司名可切换其他公司
Axsome Therapeutics, Inc.的季度营收约是JBG SMITH Properties的1.5倍（$191.2M vs $127.6M），Axsome Therapeutics, Inc.同比增速更快（57.4% vs 5.7%），过去两年Axsome Therapeutics, Inc.的营收复合增速更高（48.1% vs -2.9%）
Jazz Pharmaceuticals是一家全球生物制药企业，专注于肿瘤学与神经科学领域的药物研发及商业化。公司2003年在美国加利福尼亚州成立，目前总部位于爱尔兰都柏林，业务覆盖全球多个核心市场。
JBG SMITH Properties是一家总部位于马里兰州贝塞斯达的上市房地产投资信托公司，专注于持有并运营房地产资产，是美国商业地产领域的专业运营机构，面向市场提供多元化的不动产投资与管理服务。
AXSM vs JBGS — 直观对比
营收规模更大
AXSM
是对方的1.5倍
$127.6M
营收增速更快
AXSM
高出51.7%
5.7%
两年增速更快
AXSM
近两年复合增速
-2.9%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $191.2M | $127.6M |
| 净利润 | — | $-23.0M |
| 毛利率 | — | — |
| 营业利润率 | -33.1% | — |
| 净利率 | — | -18.1% |
| 营收同比 | 57.4% | 5.7% |
| 净利润同比 | — | 57.1% |
| 每股收益（稀释后） | — | $-0.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXSMJBGS
| Q1 26 | $191.2M | $127.6M | ||
| Q4 25 | $196.0M | $127.6M | ||
| Q3 25 | $171.0M | $123.9M | ||
| Q2 25 | $150.0M | $126.5M | ||
| Q1 25 | $121.5M | $120.7M | ||
| Q4 24 | $118.8M | $130.8M | ||
| Q3 24 | $104.8M | $136.0M | ||
| Q2 24 | $87.2M | $135.3M |
净利润AXSMJBGS
| Q1 26 | — | $-23.0M | ||
| Q4 25 | $-28.6M | $-45.5M | ||
| Q3 25 | $-47.2M | $-28.6M | ||
| Q2 25 | $-48.0M | $-19.2M | ||
| Q1 25 | $-59.4M | $-45.7M | ||
| Q4 24 | $-74.9M | $-59.9M | ||
| Q3 24 | $-64.6M | $-27.0M | ||
| Q2 24 | $-79.3M | $-24.4M |
营业利润率AXSMJBGS
| Q1 26 | -33.1% | — | ||
| Q4 25 | -13.8% | -47.5% | ||
| Q3 25 | -27.0% | -27.5% | ||
| Q2 25 | -24.5% | -18.4% | ||
| Q1 25 | -46.9% | -44.7% | ||
| Q4 24 | -61.1% | -53.6% | ||
| Q3 24 | -59.8% | -22.4% | ||
| Q2 24 | -89.5% | -24.3% |
净利率AXSMJBGS
| Q1 26 | — | -18.1% | ||
| Q4 25 | -14.6% | -35.7% | ||
| Q3 25 | -27.6% | -23.1% | ||
| Q2 25 | -32.0% | -15.2% | ||
| Q1 25 | -48.9% | -37.9% | ||
| Q4 24 | -63.1% | -45.8% | ||
| Q3 24 | -61.7% | -19.8% | ||
| Q2 24 | -91.0% | -18.0% |
每股收益（稀释后）AXSMJBGS
| Q1 26 | — | $-0.32 | ||
| Q4 25 | $-0.55 | $-0.76 | ||
| Q3 25 | $-0.94 | $-0.48 | ||
| Q2 25 | $-0.97 | $-0.29 | ||
| Q1 25 | $-1.22 | $-0.56 | ||
| Q4 24 | $-1.54 | $-0.70 | ||
| Q3 24 | $-1.34 | $-0.32 | ||
| Q2 24 | $-1.67 | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $305.1M | — |
| 总债务越低越好 | $70.0M | — |
| 股东权益账面价值 | — | — |
| 总资产 | $713.6M | $4.3B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AXSMJBGS
| Q1 26 | $305.1M | — | ||
| Q4 25 | $322.9M | $75.3M | ||
| Q3 25 | $325.3M | $64.4M | ||
| Q2 25 | $303.0M | $61.4M | ||
| Q1 25 | $300.9M | $81.3M | ||
| Q4 24 | $315.4M | $145.8M | ||
| Q3 24 | $327.3M | $137.0M | ||
| Q2 24 | $315.7M | $163.5M |
总债务AXSMJBGS
| Q1 26 | $70.0M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益AXSMJBGS
| Q1 26 | — | — | ||
| Q4 25 | $88.3M | $1.2B | ||
| Q3 25 | $73.7M | $1.2B | ||
| Q2 25 | $73.1M | $1.3B | ||
| Q1 25 | $53.2M | $1.6B | ||
| Q4 24 | $57.0M | $1.8B | ||
| Q3 24 | $92.9M | $1.9B | ||
| Q2 24 | $102.9M | $2.0B |
总资产AXSMJBGS
| Q1 26 | $713.6M | $4.3B | ||
| Q4 25 | $689.8M | $4.4B | ||
| Q3 25 | $669.3M | $4.4B | ||
| Q2 25 | $639.8M | $4.5B | ||
| Q1 25 | $596.7M | $4.7B | ||
| Q4 24 | $568.5M | $5.0B | ||
| Q3 24 | $561.5M | $5.2B | ||
| Q2 24 | $548.2M | $5.3B |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AXSM
| Product sales, net | $189.4M | 99% |
| Royalty revenue and milestone revenue | $1.8M | 1% |
JBGS
| Property rental | $105.9M | 83% |
| Third-party real estate services, including reimbursements | $17.2M | 13% |
| Other revenue | $4.5M | 4% |
